AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: emerging targets and pharmacodynamics.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D023381:Endpoint Determination; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D018841:HSP90 Heat-Shock Proteins / Q000187:drug effects; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D012958:Societies, Scientific; D014481:United States
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D018841:HSP90 Heat-Shock Proteins; D056572:Histone Deacetylase Inhibitors